Eridani Pharmaceuticals

Eridani, is a PA based company focused on developing innovative therapies to treat serious antibiotic resistant infections including MRSA, VRE and C Difficile.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jamison, Pennsylvania, US
  • Currency USD
  • Founded April 2014
  • Employees 2
  • Website lazaruspharma.com

Company Summary

Eridani Pharmaceuticals, Inc is a portfolio company of Lazarus Pharmaceuticals, LLC. Lazarus Pharmaceuticals operates under a holding company model with a portfolio of companies each dedicated to developing a particular asset. Lazarus is constructing a pipeline of product candidates for the treatment of G.I. diseases including serious G.I. Infections. NAI-603 is a novel I.V. and oral bactericidal antibiotic that treats MRSA, VRE and C. Diff .

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free